Why not immunize all children under the age of 59 months with pneumococcal vaccine? Vaccination for infants and children would provide an effective means for reducing the mortality and morbidity of pneumococcal disease. Pneumococcus (streptococcus pneumoniae) is responsible for infections such as otitis media, pneumonia, meningitis, and septicemia. According to the Centers for Disease Control and Prevention, pneumococcus is responsible for 40,000 deaths per year in the United States (Centers for Disease Control and Prevention [CDC], 1997). Pneumococcus is a nondiscriminatory infectious agent affecting all ages, sexes, and races. Children, by nature oftheir immature immunologic status, are susceptible to pneumococcal infections. Children in daycare centers with greater than 10 children hold an even higher risk for infection. They are 6 to 36 times more likely to suffer from pneumococcal infection than their peers who are not in daycare (CDC, 1997). Vaccines are available that can provide up to 90% protection against the most common pneumococcal strains (O'Brien et aI., 1996). Current recommendations limit their use to children under 2 years, and in certain select populations. Use of vaccines in children up to five years of age would provide an effective means of decreasing pneumococcal disease.
Metrics
1 File views/ downloads
11 Record Views
Details
Title
Recommendations for the Use of Heptavalent Pneumococcal Vaccine
Creators
Michael G.L. Sells
Contributors
Billie M. Severtsen (Advisor)
Awarding Institution
Washington State University
Academic Unit
Research Projects, College of Nursing
Theses and Dissertations
Master of Nursing (MN), Washington State University
Publisher
Washington State University; Spokane, Washington
Identifiers
99900590729101842
Copyright
http://creativecommons.org/licenses/by-nc-sa/3.0/us; Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States (CC BY-NC-SA 3.0 US)